MUTAGENESIS

Scope & Guideline

Leading the charge in mutagenesis research since 1986.

Introduction

Explore the comprehensive scope of MUTAGENESIS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore MUTAGENESIS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0267-8357
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1986 to 2024
AbbreviationMUTAGENESIS / Mutagenesis
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

MUTAGENESIS focuses on the intricate relationship between mutations, genetic toxicology, and environmental factors. The journal aims to provide a platform for high-quality research that advances our understanding of mutagenesis and its implications in health and disease.
  1. Genotoxicity Assessment:
    The journal emphasizes studies that evaluate the genotoxic potential of various substances using in vitro and in vivo methodologies, including the development and validation of novel assays.
  2. Molecular Mechanisms of Mutagenesis:
    Research exploring the underlying molecular and cellular mechanisms that lead to mutations, including DNA damage responses and repair pathways, is a core area of focus.
  3. Environmental and Occupational Health:
    Papers addressing the impact of environmental pollutants and occupational exposures on genetic stability and health outcomes are prominently featured, highlighting the journal's commitment to public health.
  4. Cancer Genetics and Epigenetics:
    The journal publishes research on the genetic and epigenetic factors contributing to cancer development, including studies on specific gene mutations and their clinical implications.
  5. Innovative Therapeutics:
    A unique contribution of the journal is its focus on next-generation therapeutics and their role in mitigating genetic damage and cancer risk, integrating basic research with clinical applications.
Recent publications in MUTAGENESIS highlight several emerging themes and trends that are gaining traction within the field of genetic toxicology. These themes reflect contemporary scientific interests and societal concerns.
  1. MicroRNA and Gene Regulation:
    Research investigating the role of microRNAs in cancer chemoresistance and genetic instability is on the rise, indicating a growing interest in post-transcriptional regulation as a factor in mutagenesis.
  2. Impact of COVID-19 on Genetic Stability:
    Studies exploring the genetic effects of COVID-19 and its long-term implications on health outcomes are emerging, reflecting the pandemic's influence on research priorities.
  3. Nanomaterials and Genotoxicity:
    An increasing number of papers are focusing on the genotoxic potential of nanomaterials, showcasing the need for updated risk assessments in light of their widespread use.
  4. Environmental Mutagenesis:
    A notable trend is the increasing emphasis on environmental factors and their contributions to genetic damage, particularly in relation to air pollution and chemical exposures.
  5. 3D and In Vitro Models:
    There is a growing interest in the development and application of advanced in vitro models, including 3D tissue constructs, for more accurate assessments of genotoxicity and cancer risk.

Declining or Waning

While MUTAGENESIS has consistently explored various themes, certain areas of research appear to be declining in prominence over recent years. This section outlines these waning themes.
  1. Traditional Genotoxicity Testing Methods:
    The focus on classical genotoxicity assays, such as the Ames test and micronucleus assays, has decreased as newer methodologies and technologies are being developed and adopted.
  2. Single-Agent Toxicity Studies:
    Research concentrating solely on the effects of individual genotoxic agents is becoming less frequent, as there is a growing interest in understanding combined effects and real-world exposures.
  3. Basic Toxicology without Molecular Insights:
    Studies that provide basic toxicological data without delving into molecular mechanisms or implications for human health are increasingly rare, reflecting a shift towards more integrative research approaches.

Similar Journals

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Fostering Innovation in Molecular Toxicology Research
Publisher: WILEYISSN: 1095-6670Frequency: 12 issues/year

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

Toxicological Research

Elevating toxicological research to new heights of understanding.
Publisher: KOREAN SOC TOXICOLOGYISSN: 1976-8257Frequency: 4 issues/year

Toxicological Research is a prominent academic journal dedicated to advancing the field of toxicology through rigorous exploration and innovative research. Published by the Korean Society of Toxicology, this journal serves as a vital resource for researchers, professionals, and students engaged in environmental science, pharmacology, and toxicology. With an ISSN of 1976-8257 and an E-ISSN of 2234-2753, Toxicological Research highlights significant findings and discussions in the realm of health, toxicology, and mutagenesis. Although not an open-access journal, it maintains a solid reputation as evidenced by its Q3 ranking in both health-related toxicology and general toxicology categories for 2023. The journal covers a broad spectrum of topics from fundamental research to applied toxicology and provides a unique platform for the dissemination of knowledge in a field that is increasingly relevant in today’s society. With an anticipated convergence period from 2008 to 2024, Toxicological Research continues to contribute vital insights to understanding the implications of toxic substances on health and the environment.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Empowering Scholars in the Field of Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Emerging Contaminants

Bridging research and real-world impact on health.
Publisher: KEAI PUBLISHING LTDISSN: 2405-6650Frequency: 1 issue/year

Emerging Contaminants is a leading international journal dedicated to the exploration and analysis of novel pollutants, their effects, and the methodologies for their detection and remediation. Published by KEAI PUBLISHING LTD in China, this Open Access journal has been at the forefront of scientific discourse since its inception in 2015, allowing unrestricted access to cutting-edge research. With an impressive categorization in the top Q1 quartile across diverse fields, including Health, Toxicology and Mutagenesis, and Public Health, it ranks remarkably high—41st out of 665 in Public Health and 10th out of 133 in Toxicology according to Scopus metrics, demonstrating its vital role in advancing our understanding of environmental health risks. By bridging the gap between academia and practical applications, Emerging Contaminants not only enriches the scientific community but also serves as an essential resource for policymakers and industry leaders seeking effective solutions to environmental challenges. Researchers, professionals, and students alike are encouraged to engage with the journal’s comprehensive studies and findings, contributing to a sustainable future.

Toxicology Research

Exploring the intersection of health and environment.
Publisher: OXFORD UNIV PRESSISSN: 2045-452XFrequency: 6 issues/year

Toxicology Research is a distinguished journal dedicated to advancing the field of toxicology through the dissemination of high-quality research. Published by Oxford University Press, this UK-based journal focuses on critical aspects of toxicology and mutagenesis, highlighting both environmental and pharmacological implications. With an ISSN of 2045-452X and an E-ISSN of 2045-4538, it serves as a valuable resource for researchers, professionals, and students alike. Currently categorized in the Q3 quartile for Health, Toxicology and Mutagenesis, as well as Toxicology in 2023, Toxicology Research maintains a visible presence in Scopus rankings, positioning itself within the targeted professional community. Although the journal operates without open access options, its importance in contributing to scientific discussions and policy formation is undeniable. Covering content from 2012 to 2024, it continues to provide insights into contemporary toxicological challenges, thereby fostering interdisciplinary collaborations and informing best practices in health and safety.

Life Science Alliance

Transforming Ideas into Impactful Science.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

Genetics Research

Driving Progress in Genetic and Medical Sciences
Publisher: HINDAWI LTDISSN: 0016-6723Frequency: 1 issue/year

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Epigenomes

Empowering Researchers Through Open Access Insights
Publisher: MDPIISSN: Frequency: 4 issues/year

Epigenomes is a distinguished open access journal published by MDPI, dedicated to advancing the field of epigenetics and its interdisciplinary connections to biochemistry, genetics, and molecular biology. Since its inception in 2017, this journal has provided a transparent platform for researchers to share their findings, contributing to a deeper understanding of epigenetic mechanisms and their implications in health, toxicology, and mutagenesis. Ranked in the Q2 quartile across multiple categories, including biochemistry and genetics, Epigenomes is recognized for its scholarly contributions, reflected in its notable Scopus rankings. Readers benefit from a wealth of open access articles, fostering innovation and collaboration within the academic community. With its headquarters in Switzerland and an unwavering commitment to scientific rigor, Epigenomes is positioned as a vital resource for researchers, professionals, and students seeking to deepen their insights into the epigenomic landscape.

INDUSTRIAL HEALTH

Elevating Standards in Environmental and Occupational Health
Publisher: NATL INST OCCUPATIONAL SAFETY & HEALTH, JAPANISSN: 0019-8366Frequency: 6 issues/year

INDUSTRIAL HEALTH is a premier journal dedicated to the dissemination of innovative research in the fields of public health, environmental and occupational health, as well as toxicology and mutagenesis. Published by the National Institute of Occupational Safety and Health in Japan, the journal has been a critical resource for over six decades, covering essential topics from 1963 to the present day. With an impressive placement in the second quartile (Q2) of the Public Health, Environmental and Occupational Health category and a third quartile (Q3) in Health, Toxicology, and Mutagenesis, it is recognized for its significant contribution to advancing knowledge and improving practices within the industry. While not an open-access journal, INDUSTRIAL HEALTH offers researchers and students access to a wealth of knowledge through its rich archive of articles, fostering a deeper understanding of health and safety challenges in industrial settings. The journal’s dedication to high-quality research and its strategic role in promoting occupational safety make it an invaluable asset for professionals seeking to enhance health standards and safety protocols worldwide.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Illuminating the Pathways of Mutagenesis Research
Publisher: ELSEVIERISSN: 1383-5742Frequency: 4 issues/year

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, published by Elsevier, stands as a premier journal in the fields of Genetics and Health, Toxicology and Mutagenesis, boasting a Q1 ranking in both categories for 2023. With an impressive impact factor and rigorous peer-review process, this journal serves as a vital platform for disseminating cutting-edge research and comprehensive reviews regarding the implications of genetic mutations and related health effects. Established in the Netherlands, it has evolved from its inception in the early 1990s to become an essential resource for researchers, professionals, and students alike, facilitating advancements in the understanding of mutation research. Despite not offering an open-access model, the journal ensures a wide reach through institutional subscriptions, emphasizing its commitment to fostering scholarly dialogue and promoting significant findings within the scientific community.